106 related articles for article (PubMed ID: 26040224)
21. [Retinoblastoma regression patterns and results following chemo reduction and adjuvant therapy].
Xue K; Qian J; Yue H; Yuan YF; Zhang R
Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):625-30. PubMed ID: 22943868
[TBL] [Abstract][Full Text] [Related]
22. Retinoblastoma: An update.
Delhiwala KS; Vadakkal IP; Mulay K; Khetan V; Wick MR
Semin Diagn Pathol; 2016 May; 33(3):133-40. PubMed ID: 26969537
[TBL] [Abstract][Full Text] [Related]
23. The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common.
Sitorus RS; Moll AC; Suhardjono S; Simangunsong LS; Riono P; Imhof S; Völker-Dieben HJ
Ophthalmic Genet; 2009 Mar; 30(1):31-6. PubMed ID: 19172508
[TBL] [Abstract][Full Text] [Related]
24. Clinical manifestations and treatment of retinoblastoma in Kobe children's hospital for 16 years.
Okimoto S; Nomura K
J Pediatr Ophthalmol Strabismus; 2014 Jul; 51(4):222-9. PubMed ID: 24844394
[TBL] [Abstract][Full Text] [Related]
25. The development of young children with retinoblastoma.
Ross G; Lipper EG; Abramson D; Preiser L
Arch Pediatr Adolesc Med; 2001 Jan; 155(1):80-3. PubMed ID: 11177067
[TBL] [Abstract][Full Text] [Related]
26. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
27. Outcomes in retinoblastoma, 1974-2005: the Children's Hospital, Westmead.
Berman EL; Donaldson CE; Giblin M; Martin FJ
Clin Exp Ophthalmol; 2007; 35(1):5-12. PubMed ID: 17300564
[TBL] [Abstract][Full Text] [Related]
28. Metastatic retinoblastoma clinical features, treatment, and prognosis.
Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
[TBL] [Abstract][Full Text] [Related]
29. Retinoblastoma.
Rodriguez-Galindo C; Orbach DB; VanderVeen D
Pediatr Clin North Am; 2015 Feb; 62(1):201-23. PubMed ID: 25435120
[TBL] [Abstract][Full Text] [Related]
30. Retinoblastoma in Nepal: a clinical profile of 30 cases.
Saiju R; Thakur J; Karmacharya PC; Shah DN
Nepal Med Coll J; 2006 Sep; 8(3):171-5. PubMed ID: 17203823
[TBL] [Abstract][Full Text] [Related]
31. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.
Naseripour M; Nazari H; Bakhtiari P; Modarres-zadeh M; Vosough P; Ausari M
Br J Ophthalmol; 2009 Jan; 93(1):28-32. PubMed ID: 18952647
[TBL] [Abstract][Full Text] [Related]
32. Retinoblastoma.
Mehta M; Sethi S; Pushker N; Kashyap S; Sen S; Bajaj MS; Ghose S
Singapore Med J; 2012 Feb; 53(2):128-35; quiz 136. PubMed ID: 22337189
[TBL] [Abstract][Full Text] [Related]
33. Team management, twinning, and telemedicine in retinoblastoma: a 3-tier approach implemented in the first eye salvage program in Jordan.
Qaddoumi I; Nawaiseh I; Mehyar M; Razzouk B; Haik BG; Kharma S; Jaradat I; Rodriguez-Galindo C; Wilson MW
Pediatr Blood Cancer; 2008 Aug; 51(2):241-4. PubMed ID: 18300320
[TBL] [Abstract][Full Text] [Related]
34. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria.
Sovinz P; Urban C; Lackner H; Benesch M; Langmann G
Wien Klin Wochenschr; 2006 Feb; 118(1-2):22-30. PubMed ID: 16489522
[TBL] [Abstract][Full Text] [Related]
35. Fertility preservation in the male pediatric population: factors influencing the decision of parents and children.
Wyns C; Collienne C; Shenfield F; Robert A; Laurent P; Roegiers L; Brichard B
Hum Reprod; 2015 Sep; 30(9):2022-30. PubMed ID: 26141713
[TBL] [Abstract][Full Text] [Related]
36. Technology use and interest among low-income parents of young children: differences by age group and ethnicity.
Swindle TM; Ward WL; Whiteside-Mansell L; Bokony P; Pettit D
J Nutr Educ Behav; 2014; 46(6):484-90. PubMed ID: 25087748
[TBL] [Abstract][Full Text] [Related]
37. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
[TBL] [Abstract][Full Text] [Related]
38. Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children's Hospital Los Angeles experience.
Berry JL; Jubran R; Wong K; Lee TC; Murphree AL; Kim JW
Br J Ophthalmol; 2014 Aug; 98(8):1061-5. PubMed ID: 24671926
[TBL] [Abstract][Full Text] [Related]
39. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
[TBL] [Abstract][Full Text] [Related]
40. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
